Australia's Medicinal Cannabis Industry Faces Scrutiny Amid Legal Challenges

Montu, a leading player in the sector, is embroiled in a legal battle over advertising practices, raising concerns about regulation and ethics.

A major investigation reveals that Montu, Australia's largest medicinal cannabis company, is under legal scrutiny for allegedly violating advertising laws.
The Therapeutic Goods Administration has taken Montu to court, accusing it of illegal marketing tactics, including a contentious referral scheme.
Montu's rapid growth has sparked debate over the industry's ethics and regulatory oversight, with calls for stricter compliance to protect consumers.
The booming industry, legal since 2016, now includes nearly 3000 approved providers and has seen a surge in telehealth cannabis prescriptions.
Industry insiders warn that aggressive marketing could undermine the sector's legitimacy, emphasizing the need for patient-centered care.